PEPG

PepGen Inc. Common Stock (PEPG)

Stock · NASDAQ · Health Care

$2.58as of 10/16/2026

Active signals

Support level
$1.69
Industry
Biotechnology: Pharmaceutical Preparations

What PEPG's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike40+2.4%53%
Bollinger Band Breakout22+1.3%50%
Bollinger Band Breakdown16-2.0%50%
200-Day Moving Average TouchActive now3-17.8%33%
Any 20-session window (baseline)-2.6%45%

Computed by MarketWall from daily closing prices since February 22, 2023. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About PEPG

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystr…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
57
Website
pepgen.com

Fundamentals

1-day range
$2.5$2.69
Market cap
$166.70M
P/E (trailing)
—
P/E (forward)
-2.39
EPS (trailing)
$-1.30
Dividend yield
—
Beta
1.99
Avg. volume
855.2K
52-week range
$1.31$7.8
Next earnings: November 11, 2026 · EPS estimate $-0.27confirmed

Forecasts

8 analyst ratings

Buy 86%
Hold 7%
Sell 7%
1-year price forecast
High
$20
+675.2%
Median
$10.5
+307.0%
Low
$2.5
-3.1%

PepGen Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • PEPG
    PepGen Inc. Common Stock
    $2.6
    ▲ 2.77%
    Market cap $166.70MP/E —
    $1.31$7.8
  • INDP
    Indaptus Therapeutics Inc. Common Stock
    $2.63
    ▼ 7.72%
    Market cap $166.55MP/E —
    $0.92$5.96
  • OKUR
    OnKure Therapeutics Inc. Class A Common Stock
    $2.1
    ▼ 1.41%
    Market cap $168.06MP/E —
    $2.13$5.38
  • NKTX
    Nkarta Inc. Common Stock
    $1.8
    ▼ 6.74%
    Market cap $163.84MP/E —
    $1.7$3.72
  • ARCT
    Arcturus Therapeutics Holdings Inc. Common Stock
    $10.34
    ▼ 8.25%
    Market cap $172.81MP/E —
    $5.5$24.17
  • AARD
    Aardvark Therapeutics Inc. Common Stock
    $3.78
    ▼ 2.07%
    Market cap $159.75MP/E —
    $3.35$16.6
  • KRRO
    Korro Bio Inc. Common Stock
    $8.49
    ▼ 8.81%
    Market cap $174.80MP/E —
    $5.2$55.89

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
272.0K
Disposed
1.2K
  • Wyman Lisa · June 18, 2026 · Grant
    34.0K
  • Mayer Howard · June 18, 2026 · Grant
    34.0K
  • Resnick Joshua · June 18, 2026 · Grant
    34.0K
  • Dable Habib J · June 18, 2026 · Grant
    34.0K
  • KEATING LAURIE · June 18, 2026 · Grant
    34.0K
  • Finer Mitchell H. · June 18, 2026 · Grant
    34.0K
  • RA Capital Healthcare Fund LP · June 18, 2026 · Grant
    34.0K
  • Heidi Henson · June 18, 2026 · Grant
    34.0K
  • Kasraian Kasra · May 21, 2026 · Sale
    1.2K @ $1.41

Institutional Ownership

March 31, 2026

Total shares held
56.36M
Total value held
$99.54M
Institutional holders
91
Top holders this quarter
  • Unknown20.06M
  • Unknown4.47M
  • Unknown3.48M
  • Unknown2.75M
  • Unknown2.33M
  • Unknown2.08M
  • Unknown1.94M
  • Unknown1.83M
  • Unknown1.61M
  • Unknown1.31M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.